These recommendations are based on the evidence reviewed ( Table 4). Because most trials were between 8 and 24 weeks’ duration, data on long-term use are limited. Considerations when stopping or ...

A low-dose paroxetine salt (7.5 mg/d) is the only nonhormonal pharmaceutical approved by the US Food and Drug Administration (FDA) for the treatment of moderate to severe menopausal VMS, with ...